Ordinary Adjustment | Solactive US CNS Therapeutics Index | Effective Date 12th September 2025
Solactive US CNS Therapeutics Index:
In the ordinary adjustment, the following composition will be implemented effective open 12th September 2025:
| ACADIA PHARMACEUTICALS INC |
| ALKERMES PLC |
| ANAVEX LIFE SCIENCES CORP |
| AVADEL PHARMACEUTICALS PLC |
| AXSOME THERAPEUTICS INC |
| BIOGEN INC |
| CORCEPT THERAPEUTICS INC |
| DENALI THERAPEUTICS INC |
| ELI LILLY & CO |
| HARMONY BIOSCIENCES HOLDINGS INC |
| JAZZ PHARMACEUTICALS PLC |
| NEUROCRINE BIOSCIENCES INC |
| NEW BIOHAVEN |
| PTC THERAPEUTICS INC |
| Praxis Precision Medicines Inc |
| SCHOLAR ROCK HOLDING CORP |
| SUPERNUS PHARMACEUTICALS INC |
| UNIQURE B.V. |
| VERTEX PHARMACEUTICALS INC |
| XENON PHARMACEUTICALS INC |